Skip to content
★ Sign in to follow
Polynovo Limited logo

Polynovo Limited Stock: price and insider trades · Australia

ISIN AU000000PNV0AU·Mcap A$625.2MHealth Care

Polynovo Limited: what insiders have been doing

Polynovo Limited is a Health Care company based in Australia. Its directors and officers file their transactions with ASX. 8 insiders have disclosed 16 filings since 3 November 2025.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

There has been no open-market purchase by an insider of Polynovo Limited for at least a year.

Across the 1,619 companies tracked on its exchange, the median is 5 filings; at 16 filings, this issuer sits above that mark.

In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Source: insider filings from ASX. Past trades are no guide to future returns.

Key facts

Headquarters: Australia

Source: Wikidata (CC0).

Insider Decl.
16
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 15,603 of 26,911 companies
46.8
score / 100
Value
29
Quality
65
FCF yld1.5%
Earn yld1.2%
EV/EBITDA58.8x
ROE8.4%
Gross mgn89%
Net mgn5.1%
Debt/EBITDA1.6x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended June 2026 · cache

A$0.91
Analyst consensus
7 analysts
1.57/5
A$0.95Target A$1.25(+39%)A$1.70
Income statement
RevenueA$143.7M
Gross profitA$128.5M89% margin
EBITDAA$10.8M7% margin
Net incomeA$7.3M4.9% margin
Valuation
PER (trailing)90.5x
PER (forward)33.2x
P/Book6.9x
Beta1.35
Balance sheet & cash
Market capA$625.2M
Total debtA$17.6M
Free Cash FlowA$9.3M
Debt / Equity19%
Profitability & ownership
ROE8.4%
ROA6.4%
% insiders10.0%
% institutions30.6%
Last declaration on 2 November 2026
Declarations16 total

16 of 16 declarations

About Polynovo Limited

Polynovo Limited is an Australian Securities Exchange listed company focused on developing innovative medical devices. It primarily concentrates on wound care solutions and biomaterial implants.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations